Pharmaceutical CTD / eCTD Dossier Preparation
Complete compilation of CTD-format dossiers — including Drug Information Files, stability studies, preclinical/clinical data, and quality modules — tailored to SFDA submission standards.
Navigate the Saudi Food and Drug Authority's requirements with confidence. Medwisdom Lifescience delivers end-to-end SFDA compliance — from eCTD dossier preparation and pharmaceutical registration to medical device MDMA/MDNR listing and cosmetics notification.
Saudi Arabia is the largest pharmaceutical market in the Gulf Cooperation Council (GCC) region, driven by robust population growth, Vision 2030 healthcare investments, and an expanding demand for high-quality medicines and medical technologies.
The Saudi Food and Drug Authority (SFDA) is the central regulatory body overseeing the licensing, manufacturing, importation, distribution, and promotion of medicinal products, medical devices, and cosmetics. The SFDA enforces rigorous scientific standards to ensure that only safe, effective, and high-quality products reach Saudi patients.
Medwisdom Lifescience specializes in helping global manufacturers understand and fulfill SFDA requirements — accelerating your path to market authorization and long-term regulatory compliance in this strategically vital Middle Eastern market.
Start Your SFDA JourneyKey compliance milestones for market entry in Saudi Arabia:
From initial dossier compilation to post-market obligations, Medwisdom provides complete regulatory lifecycle support across pharmaceuticals, medical devices, and cosmetics.
Complete compilation of CTD-format dossiers — including Drug Information Files, stability studies, preclinical/clinical data, and quality modules — tailored to SFDA submission standards.
End-to-end management of SFDA marketing authorization applications for new drug registrations, license renewals, and post-approval variation notifications.
Expert management of electronic submissions via the SFDA portal, including document formatting, technical validation, query-response tracking, and timeline management throughout the review cycle.
Comprehensive GMP gap assessments, audit readiness programs, and SFDA GMP certification support for manufacturing facilities seeking Saudi market authorization.
Full guidance through the Medical Device Marketing Authorization (MDMA) and National Registry (MDNR) listing processes — including classification, technical file compilation, and SFDA liaison support.
Ongoing monitoring of SFDA medical device regulations, classification updates, and evolving compliance requirements to keep global manufacturers informed and audit-ready.
Rapid, accurate preparation of scientific and administrative responses to SFDA queries during product review — minimizing assessment delays and protecting approval timelines.
Bilingual label review, SFDA-specific artwork requirements (patient information leaflets, packaging artwork, mock-up approval), and readability validation for compliant Saudi product labeling.
Regulatory pathway determination, borderline product assessment, ingredient safety review against SFDA prohibited/restricted lists, and electronic cosmetics notification via the SFDA portal.
Ingredient compliance evaluation, cosmetic product safety reports, and formulation audits aligned with SFDA cosmetics regulations and GCC harmonized guidelines.
Preparation and submission of post-approval variation dossiers for changes in formulation, manufacturing site, packaging, or labeling — maintaining uninterrupted market authorization validity.
Proactive monitoring of SFDA policy updates, regulatory guidance revisions, and GCC harmonization developments to help you build a robust, future-proof Saudi market strategy.
A structured, milestone-driven approach that ensures compliant, efficient market authorization in Saudi Arabia.
Review product data, classify the product, and identify SFDA submission pathway and documentation gaps.
Prepare CTD/eCTD dossier modules — Quality, Non-Clinical, Clinical, and Administrative — per SFDA guidelines.
Internal QC check and regulatory review to ensure completeness and compliance before portal submission.
Electronic submission via the official SFDA regulatory portal with technical validation confirmation.
Prompt, science-backed responses to SFDA assessment queries to keep approvals on schedule.
Obtain SFDA marketing authorization and support with post-approval obligations and lifecycle management.
We combine deep regulatory expertise with responsive service delivery to help you achieve compliant, timely market entry in Saudi Arabia.
Our regulatory scientists have hands-on experience navigating SFDA requirements across pharmaceuticals, medical devices, and cosmetics.
Rigorous pre-submission reviews and proactive query management minimize assessment cycles and protect your launch timelines.
With expertise spanning 40+ countries, we align your Saudi submission strategy with your broader global regulatory portfolio.
From first assessment through post-market compliance, we support your product's full regulatory lifecycle in Saudi Arabia.
Precise Arabic/English labeling, regulatory correspondence, and document preparation that meets SFDA's language requirements.
We monitor SFDA updates in real time so you're never caught off guard by regulatory changes affecting your products.
Answers to the most common questions about pharmaceutical and medical device registration with SFDA in Saudi Arabia.
The Saudi Food and Drug Authority (SFDA) is Saudi Arabia's national regulatory body responsible for overseeing the safety, efficacy, and quality of pharmaceutical products, medical devices, and cosmetics. It governs the registration, manufacturing, importation, exportation, distribution, and promotion of these products in the Kingdom.
Yes. SFDA requires pharmaceutical dossiers to be submitted in CTD (Common Technical Document) format. eCTD (electronic CTD) is strongly recommended and progressively being mandated. Medwisdom's eCTD specialists ensure your dossier meets all SFDA technical and content requirements for seamless electronic submission.
SFDA review timelines vary depending on the product type and submission pathway. New chemical entities typically take 12–18 months, while generics may take 6–12 months. Proactive query management, complete dossier submission, and GMP compliance can significantly reduce overall timelines.
The Medical Device Marketing Authorization (MDMA) is a full marketing authorization required for higher-risk medical devices sold in Saudi Arabia. The Medical Device National Registry (MDNR) is a listing mechanism for certain lower-risk devices. The appropriate pathway depends on the device's risk classification under SFDA's medical device regulations.
Yes. Cosmetic products must be notified to SFDA via the official electronic portal before commercialization in Saudi Arabia. The notification process involves product classification, ingredient compliance review, safety assessment, and documentation submission — all of which Medwisdom manages on your behalf.
Yes. SFDA requires product labels, patient information leaflets, and packaging artwork in Arabic (and typically also in English). Labels must comply with SFDA-specific formatting, content, and readability requirements. Medwisdom provides bilingual labeling review and mock-up approval support to ensure full compliance.
From initial dossier preparation and SFDA submissions to medical device registration, cosmetics notification, and ongoing post-market compliance — Medwisdom Lifescience is your dedicated regulatory partner for long-term success in Saudi Arabia.